Alessandro Accetta

Alessandro Accetta

Auto-generated profile, based on publicly available information

Alessandro Accetta

Medicinal Chemistry and Drug Design Technologies Dept., Global Research and Development, Chiesi Farmaceutici S.p.A, Parma, Italy

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPaolo Bruno
Paolo Bruno
DPDaniele Pala
Daniele Pala
AMAlessandra Micoli
Alessandra Micoli
MCMauro Corsi
Mauro Corsi
AAAlessandro Accetta
Alessandro Accetta
ACAnna Maria Capelli
Anna Maria Capelli

16 September 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DPDaniele Pala
Daniele Pala
DCDavid Clark
David Clark
CEChristine Edwards
Christine Edwards
EPElisa Pasqua
Elisa Pasqua
LTLaura Tigli
Laura Tigli
AAAlessandro Accetta
Alessandro Accetta
We report the characterization of potent and selective ROCK inhibitors identified through a core-hopping strategy. A virtual screening workflow, combining ligand- and structure-based methods, was applied on a known series of ROCK inhibitors bearing an acetamido-thiazole scaffold. The most promising replacement of the central core was represented by a benzoazepinone ring, which was selected as a starting point for a subsequent chemical exploration. The overall design approach exploited previous SARs available for congeneric series and crystallographic information to optimize the hinge-binding group as well as the terminal aromatic moiety interacting with the glycine-rich loop. The introduction of elongated and flexible charged groups led to compound 15, which exhibited sub-nanomolar potencies in biochemical and cellular assays, as well as a remarkable selectivity over PKA. HDX studies not only supported the postulated binding mode of compound 15 but also confirmed the crucial role of specific ROCK peptide segments in driving ligand selectivity.

20 December 2024 in Tetrahedron Letters
Verified
Journal Article
Closed access
IBIva Brekalo
Iva Brekalo
ZIZorica Marušić Ištuk
Zorica Marušić Ištuk
MMMilan Mesić
Milan Mesić
MČMarijo Čičak
Marijo Čičak
IEIvaylo J. Elenkov
Ivaylo J. Elenkov
AAAlessandro Accetta
Alessandro Accetta

30 September 2026 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
TPTracey Pirali
Tracey Pirali
AAAlessandro Accetta
Alessandro Accetta
JRJarkko Rautio
Jarkko Rautio
LCLaura Carzaniga
Laura Carzaniga